Description

Octaplas LG AV (ІV) Solution for Infusions 45-70 mg. 200 ml

Ingredients

Octaplas LG AV contains a combination of essential plasma proteins, including albumin, immunoglobulins, and coagulation factors.

Dosage

The recommended dosage of Octaplas LG AV for infusions is 45-70 mg per 200 ml. Dosage may vary based on the patient’s condition and medical history.

Indications

Octaplas LG AV is indicated for the treatment of various conditions requiring replacement of multiple plasma proteins.

Contraindications

Do not use Octaplas LG AV if the patient has a history of hypersensitivity to plasma-derived products or any of the components in the solution.

Directions

Administer Octaplas LG AV intravenously as directed by a healthcare professional. Monitor the patient closely during infusion for any adverse reactions.

Scientific Evidence

Studies have shown the efficacy of Octaplas LG AV in treating patients with coagulation disorders and immunodeficiencies. Research has demonstrated its ability to restore plasma protein levels effectively.

Additional Information

Octaplas LG AV undergoes stringent quality control measures to ensure safety and efficacy. It is a reliable option for patients requiring plasma protein replacement therapy.

Pharmacologically, Octaplas LG AV works by replenishing deficient plasma proteins, thereby restoring the body’s hemostatic and immunological functions. This solution plays a crucial role in managing conditions such as clotting disorders and immune deficiencies.

Clinical trials have highlighted the superior efficacy of Octaplas LG AV compared to traditional plasma products. Its balanced composition of essential proteins offers a more targeted and efficient treatment approach, leading to improved patient outcomes and reduced treatment durations.